1. Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study. Issue 3 (4th March 2017) Authors: Pozzi, Samantha; Gentile, Massimo; Sacchi, Stefano; Marcheselli, Raffaella; Corso, Alessandro; Cocito, Federica; Musto, Pellegrino; Guarini, Attilio; Minoia, Carla; Vincelli, Iolanda; Ria, Roberto; Rivolti, Elena; Mele, Giuseppe; Bari, Alessia; Mazzone, Carla; Badiali, Stefania; Marcheselli, Luig... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 3(2017) Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse. (2nd January 2020) Authors: Montefusco, Vittorio; Corso, Alessandro; Galli, Monica; Ardoino, Ilaria; Pezzatti, Sara; Carniti, Cristina; Patriarca, Francesca; Gherlinzoni, Filippo; Zambello, Renato; Sammassimo, Simona; Marcatti, Magda; Nozza, Andrea; Crippa, Claudia; Cafro, Anna Maria; Baldini, Luca; Corradini, Paolo Journal: British journal of haematology Issue: Volume 188:Number 6(2020) Page Start: 907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Central nervous system involvement by multiple myeloma: A multi‐institutional retrospective study of 172 patients in daily clinical practice. Issue 6 (24th April 2016) Authors: Jurczyszyn, Artur; Grzasko, Norbert; Gozzetti, Alessandro; Czepiel, Jacek; Cerase, Alfonso; Hungria, Vania; Crusoe, Edvan; Silva Dias, Ana Luiza Miranda; Vij, Ravi; Fiala, Mark A.; Caers, Jo; Rasche, Leo; Nooka, Ajay K.; Lonial, Sagar; Vesole, David H.; Philip, Sandhya; Gangatharan, Shane; Druzd‐... Journal: American journal of hematology Issue: Volume 91:Issue 6(2016:Jun.) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Issue 10 (October 2020) Authors: Passamonti, Francesco; Cattaneo, Chiara; Arcaini, Luca; Bruna, Riccardo; Cavo, Michele; Merli, Francesco; Angelucci, Emanuele; Krampera, Mauro; Cairoli, Roberto; Della Porta, Matteo Giovanni; Fracchiolla, Nicola; Ladetto, Marco; Gambacorti Passerini, Carlo; Salvini, Marco; Marchetti, Monia; Lemol... Journal: Lancet Issue: Volume 7:Issue 10(2020) Page Start: e737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Corneal sub-basal neural damage pattern in multiple myeloma patients treated with bortezomib: an in vivo confocal study. Issue 12 (2nd December 2015) Authors: Cocito, Federica; Ricciardelli, Gabriella; Mangiacavalli, Silvia; Pompa, Alessandra; Pochintesta, Lara; Ferretti, Virginia; Ceccuzzi, Roberto; Cazzola, Mario; Bianchi, Paolo Emilio; Corso, Alessandro Journal: Leukemia & lymphoma Issue: Volume 56:Issue 12(2015:Dec.) Page Start: 3440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma. (30th May 2013) Authors: Mangiacavalli, Silvia; Pochintesta, Lara; Cocito, Federica; Pompa, Alessandra; Bernasconi, Paolo; Cazzola, Mario; Corso, Alessandro Journal: British journal of haematology Issue: Volume 162:Number 4(2013:Aug.) Page Start: 555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Daylight Autonomy as a Driver for Office Building Retrofitting. (September 2016) Authors: Raimondi, Alberto; Santucci, Daniele; Bevilacqua, Simone; Corso, Alessandro Journal: Energy procedia Issue: Volume 96(2016) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study. Issue 7 (August 2015) Authors: Oriol, Albert; Giraldo, Pilar; Kotsianidis, Ioannis; Couturier, Catherine; Olie, Robert; Angermund, Ralf; Corso, Alessandro Journal: Hematology Issue: Volume 20:Issue 7(2015) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study. Issue 7 (August 2015) Authors: Oriol, Albert; Giraldo, Pilar; Kotsianidis, Ioannis; Couturier, Catherine; Olie, Robert; Angermund, Ralf; Corso, Alessandro Journal: Hematology Issue: Volume 20:Issue 7(2015) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Good clinical activity and favorable toxicity profile of once weekly bortezomib, fotemustine, and dexamethasone (B‐MuD) for the treatment of relapsed multiple myeloma. Issue 2 (8th December 2012) Authors: Mangiacavalli, Silvia; Pochintesta, Lara; Pascutto, Cristiana; Cocito, Federica; Cazzola, Mario; Corso, Alessandro Journal: American journal of hematology Issue: Volume 88:Issue 2(2013:Feb.) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗